Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Gadolinium-loaded chitosan nanoparticles for neutron-capture therapy: Influence of micrometric properties of the nanoparticles on tumor-killing effect.

Ichikawa H, Uneme T, Andoh T, Arita Y, Fujimoto T, Suzuki M, Sakurai Y, Shinto H, Fukasawa T, Fujii F, Fukumori Y.

Appl Radiat Isot. 2014 Jun;88:109-13. doi: 10.1016/j.apradiso.2013.12.018. Epub 2013 Dec 27.

PMID:
24462286
3.

Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.

Tokumitsu H, Hiratsuka J, Sakurai Y, Kobayashi T, Ichikawa H, Fukumori Y.

Cancer Lett. 2000 Mar 31;150(2):177-82.

PMID:
10704740
4.

In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.

Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y.

Eur J Pharm Biopharm. 2002 Jan;53(1):57-63.

PMID:
11777753
5.
6.

Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.

Fujimoto T, Ichikawa H, Akisue T, Fujita I, Kishimoto K, Hara H, Imabori M, Kawamitsu H, Sharma P, Brown SC, Moudgil BM, Fujii M, Yamamoto T, Kurosaka M, Fukumori Y.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S355-8. doi: 10.1016/j.apradiso.2009.03.063. Epub 2009 Mar 27.

PMID:
19386506
7.

Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.

Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ.

J Control Release. 2004 Mar 24;95(3):613-26.

PMID:
15023471
8.

Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters.

Miyamoto M, Hirano K, Ichikawa H, Fukumori Y, Akine Y, Tokuuye K.

Biol Pharm Bull. 1999 Dec;22(12):1331-40.

PMID:
10746166
9.

Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.

Saha TK, Ichikawa H, Fukumori Y.

Carbohydr Res. 2006 Dec 11;341(17):2835-41. Epub 2006 Oct 11.

PMID:
17045253
10.

Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy.

Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y.

Curr Drug Deliv. 2007 Apr;4(2):131-40.

PMID:
17456032
11.

Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.

Hofmann B, Fischer CO, Lawaczeck R, Platzek J, Semmler W.

Invest Radiol. 1999 Feb;34(2):126-33.

PMID:
9951792
12.

Tumor accumulation of gadolinium in lipid-nanoparticles intravenously injected for neutron-capture therapy of cancer.

Watanabe T, Ichikawa H, Fukumori Y.

Eur J Pharm Biopharm. 2002 Sep;54(2):119-24.

PMID:
12191681
13.

MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.

Geninatti-Crich S, Alberti D, Szabo I, Deagostino A, Toppino A, Barge A, Ballarini F, Bortolussi S, Bruschi P, Protti N, Stella S, Altieri S, Venturello P, Aime S.

Chemistry. 2011 Jul 18;17(30):8479-86. doi: 10.1002/chem.201003741. Epub 2011 Jun 10.

15.

In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.

Dewi N, Mi P, Yanagie H, Sakurai Y, Morishita Y, Yanagawa M, Nakagawa T, Shinohara A, Matsukawa T, Yokoyama K, Cabral H, Suzuki M, Sakurai Y, Tanaka H, Ono K, Nishiyama N, Kataoka K, Takahashi H.

J Cancer Res Clin Oncol. 2016 Apr;142(4):767-75. doi: 10.1007/s00432-015-2085-0. Epub 2015 Dec 9.

PMID:
26650198
16.

Tumor growth suppression by gadolinium-neutron capture therapy using gadolinium-entrapped liposome as gadolinium delivery agent.

Dewi N, Yanagie H, Zhu H, Demachi K, Shinohara A, Yokoyama K, Sekino M, Sakurai Y, Morishita Y, Iyomoto N, Nagasaki T, Horiguchi Y, Nagasaki Y, Nakajima J, Ono M, Kakimi K, Takahashi H.

Biomed Pharmacother. 2013 Jul;67(6):451-7. doi: 10.1016/j.biopha.2012.11.010. Epub 2012 Dec 26.

PMID:
23743325
17.

Neutron capture therapy with gadopentetate dimeglumine: experiments on tumor-bearing rats.

Khokhlov VF, Yashkin PN, Silin DI, Djorova ES, Lawaczeck R.

Acad Radiol. 1995 May;2(5):392-8.

PMID:
9419581
18.

Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.

Le UM, Cui Z.

Int J Pharm. 2006 Apr 7;312(1-2):105-12. Epub 2006 Feb 2.

PMID:
16457973
19.

Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.

Petersen MS, Petersen CC, Agger R, Sutmuller M, Jensen MR, Sørensen PG, Mortensen MW, Hansen T, Bjørnholm T, Gundersen HJ, Huiskamp R, Hokland M.

Anticancer Res. 2008 Mar-Apr;28(2A):571-6.

20.

Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.

Zhang L, Liu Y, Yu D, Zhangl N.

J Biomed Nanotechnol. 2013 May;9(5):863-9.

PMID:
23802417

Supplemental Content

Support Center